Collectively, the inhibition of SPP1 in HCC-TAMs resulted in the down-regulation of pro-inflammatory signaling pathways (TNFα and NFκB) and relevant transcription factors (NFκB family) (Figures 7D, E). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.